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Abstract  
   In the past decade, pulmonary dysfunction has been reported due to treatment with anti-thymocyte 
globulin (ATG) in patients suffering from rejection of organ transplantation or aplastic anemia. 
Cytomegalovirus (CMV) infection is one of the common infections in recipients of organ 
transplantation. In this report, a 46 years old man underwent treatment with ATG due to rejection of 
kidney transplantation and developed pulmonary infiltration. Cytomegalovirus antigen load was 
raised in the serum. After discontinuation of ATG and treatment with ganciclovir, fibrosis and 
reduction of lung volume was developed. The resultant fibrosis was completely resolved after one 
month and the general condition of the patient was improved. In conclusion, fibrotic pattern in 
pulmonary HRCT cannot prove the irreversibility of the lesion. 
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